4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001209191-23-018472
Executive Vice President & CFO acquired 87,719 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Konidaris Tasos Executive Vice President & CFO | 2023-03-12 | Option exercise | +87,719 | 380,840 | D | ||
| Derivatives | |||||||
| Konidaris Tasos Executive Vice President & CFO | 2023-03-12 | Option exercise · Restricted Stock Units | −87,719 | 87,720 | D | ||
Loading xslF345X03/doc4.xml…